26 Jan 2017 --- Lonza has reported its full-year sales were up 8.7 percent to 4.13bn Swiss francs ($4.14bn) but the Swiss speciality ingredients supplier and pharmaceutical company was hit by a slowdown in its Agro Ingredients business. Lonza, which shelled out $5.5bn just months ago to buy the US provider of capsules for the food and healthcare industries Capsugel, said its increase in profits was courtesy of the improved running of divisions with its Consumers Care, Wood Protection and Water Treatment business performing particularly well.
